Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/14/2012WO2012079043A2 Targeting kidney mesangium with nanoparticles of defined diameter
06/14/2012WO2012079035A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
06/14/2012WO2012078999A1 Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis
06/14/2012WO2012078831A2 Smart polymeric nanoparticles which overcome multidrug resistance to cancer chemotherapeutics and treatment-related systemic toxicity
06/14/2012WO2012078815A1 Sustained release implants containing a biodegradable polymer, cyclodextrin and poorly water soluble active compounds
06/14/2012WO2012078695A2 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents
06/14/2012WO2012078667A2 Compositions and methods relating to proliferative diseases
06/14/2012WO2012078647A2 Chemical composition to detect and treat amyloid in a patient's brain and retina
06/14/2012WO2012078605A1 Topical combination formulations of macrocyclic lactones with synthetic pyrethroids
06/14/2012WO2012078528A2 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
06/14/2012WO2012078155A1 Nitric oxide and its biomedical significance
06/14/2012WO2012078121A2 Solid oral dosage form comprising cefdinir
06/14/2012WO2012078070A1 Fungicide
06/14/2012WO2012077968A2 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
06/14/2012WO2012077696A1 Stabilizer of acetaminophen
06/14/2012WO2012077651A1 Noradrenergic and specific serotonergic antidepressant-containing transdermal patch
06/14/2012WO2012077131A1 A stable ready-to-use cetrorelix injection
06/14/2012WO2012077127A1 A protein free surfactant composition for pulmonary diseases and a process for preparing the same
06/14/2012WO2012077001A2 Wipe coated with a botanical emulsion having anitmicrobial properties
06/14/2012WO2012076907A2 Dosage form
06/14/2012WO2012076897A1 Disulfiram formulation and uses thereof
06/14/2012WO2012076832A1 Suppositories comprising rifaximin
06/14/2012WO2012076718A1 Anti-microbial composition
06/14/2012WO2012076717A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012WO2012076691A1 New form of administration of enkephalinase inhibitor
06/14/2012WO2012076670A2 Antibody formulation
06/14/2012WO2012076516A1 Pharmaceutical composition comprising dutasteride
06/14/2012WO2012076443A1 Liposomal formulation of dalcetrapib
06/14/2012WO2012075744A1 Pharmaceutical composition comprising pyrazolopyrimidinone-like compound
06/14/2012WO2012075646A1 Traditional chinese medicine composition for treating infection of influenza a virus subtype and preparation method thereof
06/14/2012WO2012075575A1 Barley protein microcapsules
06/14/2012WO2012075534A1 Methods for forming miniemulsions and use thereof for delivering bioactive agents
06/14/2012WO2012075533A1 Multifunctional nanoparticles
06/14/2012WO2012052478A3 Topical gel composition
06/14/2012WO2012050896A3 Protease selective supramolecular assemblies
06/14/2012WO2012044939A3 Method of preparing a dry powder from a water bacteria extract-concentrate
06/14/2012WO2012033911A3 Polyionic papilloma virus-like particle (vlp) vaccines
06/14/2012WO2012032418A3 Activated leukocyte conditioned supernatant and uses for wound healing
06/14/2012WO2012031175A3 Nanoparticle-based tumor-targeted drug delivery
06/14/2012WO2012027731A3 Pharmaceutical composition and administrations thereof
06/14/2012WO2012020412A3 Fibrin based scaffold, preparation and use thereof
06/14/2012WO2012018240A9 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same
06/14/2012WO2011160098A4 Silk optical particles and uses thereof
06/14/2012WO2011134979A3 Stable aqueous mia/cd-rap formulations
06/14/2012WO2011127139A3 Combinations of preservative compositions for ophthalmic formulations
06/14/2012WO2011107944A3 Modified release dosage form
06/14/2012WO2011063990A8 Spider silk particles for controlled and sustained delivery of compounds
06/14/2012WO2011043913A3 Novel cationic lipids with short lipid chains for oligonucleotide delivery
06/14/2012WO2011008939A3 Porous-wall hollow glass microspheres as carriers for biomolecules
06/14/2012WO2010150144A3 Low dose pharmaceutical compositions of celecoxib
06/14/2012US20120150275 Stents and methods of making stents
06/14/2012US20120150096 Implantable or insertable medical devices for controlled drug delivery
06/14/2012US20120150087 Solid dressing for treating wounded tissue
06/14/2012US20120149843 Nanofibers and morphology shifting micelles
06/14/2012US20120148678 Sustained release of poorly water soluble active compounds
06/14/2012US20120148677 Controlled release particles containing acid fibroblast growth factor
06/14/2012US20120148676 Artificial cell constructs for cellular manipulation
06/14/2012US20120148675 Testosterone undecanoate compositions
06/14/2012US20120148674 Self-assembling hydrogels based on dicephalic peptide amphiphiles
06/14/2012US20120148673 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
06/14/2012US20120148672 Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
06/14/2012US20120148671 Gastric retained gabapentin dosage form
06/14/2012US20120148670 Sensitive polymer capsule and method of manufacturing the same
06/14/2012US20120148669 Method for preparing functionalized lipid capsules
06/14/2012US20120148668 Intracoronary device and method of use thereof
06/14/2012US20120148667 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
06/14/2012US20120148666 Anti-rsv immunogens and methods of immunization
06/14/2012US20120148665 Topical composition containing naproxen
06/14/2012US20120148664 Chemical modifications motifs for mirna inhibitors and mimetics
06/14/2012US20120148663 Lipophilic drug carrier
06/14/2012US20120148662 Formulation
06/14/2012US20120148661 High bioavailability oral picoplatin anti-cancer therapy
06/14/2012US20120148660 Conjugates of synthetic tlr agonists and uses therefor
06/14/2012US20120148659 Solid dressing for treating wounded tissue
06/14/2012US20120148658 Solid dressing for treating wounded tissue
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148656 Sheet-form preparation and method for producing the same
06/14/2012US20120148655 Multi-layered gradient vaginal ring
06/14/2012US20120148646 Radio-opaque bioactive glass materials
06/14/2012US20120148642 Multi-domain amphipathic helical peptides and methods of their use
06/14/2012US20120148641 Methods of treatment of endobronchial infections
06/14/2012US20120148640 Pharmaceutical Composition Comprising Pimobendan
06/14/2012US20120148639 Substrate for feeding cells and/or tissues, cell/tissue-feeder and method for the production of the same, method for the regeneration of tissues, and method for the production of porous bodies
06/14/2012US20120148638 Steroid Solavates
06/14/2012US20120148637 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
06/14/2012US20120148636 Microparticles and method of making microparticles
06/14/2012US20120148635 Gallium formulation for the treatment and prevention of infectious diseases
06/14/2012US20120148634 Novel formulation of naproxen
06/14/2012US20120148633 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
06/14/2012US20120148632 Methods for complex tissue engineering
06/14/2012US20120148631 Pegylated polyplexes for polynucleotide delivery
06/14/2012US20120148630 Prevention of infarct expansion
06/14/2012US20120148587 Polypeptide formulation
06/14/2012US20120148583 Cytokine antagonists for neurological and neuropsychiatric disorders
06/14/2012US20120148505 Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
06/14/2012US20120148504 Complex of garcinol, cyclodextrin and method thereof
06/14/2012US20120148503 Non-flammable insecticide composition and uses thereof
06/14/2012US20120148493 Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers
06/14/2012US20120148489 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012US20120148488 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 2991